Conjunctival Swab vs Nasopharyngeal Swab in Patients With COVID-19

Not Applicable

• Conditions: COVID-19; SARS-CoV 2

• Registration Number: NCT04444596
• Lead Sponsor: Medical University Innsbruck

Brief Summary

The aim of this possible study is to identify if SARS-CoV-2 can be found in the tear film and conjunctiva of a patient with COVID-19.

Detailed Description

Not available

Study Timeline

• Status Verified: 2020-04
• Study Start: 2020-06-17
• Study First Submitted: 2020-06-18
• Study First Submitted QC: 2020-06-22
• Last Update Submitted: 2020-06-22
• Study First Posted: 2020-06-23
• Last Update Posted: 2020-06-23
• Primary Completion: 2021-03-31
• Study Completion: 2021-03-31

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• Age ≥ 18 years
• A confirmed COVID-19 disease
• Signed and dated declaration of consent
• The patient fell ill in Tyrol

Exclusion Criteria

• none

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
SARS-CoV2 positive conjunctival swabs	1 year	The primary endpoint is the number of conjunctival swabs tested positive for SARS-CoV2.

Secondary Outcome Measures

Name	Time	Method
Conjunctival swab vs nasopharyngeal swab	1 year	The secondary target is the difference between the conjunctival swab tested positive for SARS-CoV2 and the nasopharyngeal swab.

Trial Locations

Locations (1)

Medical University Innsbruck; 🇦🇹 Innsbruck, Tirol, Austria